4-Year Check-In: how do COVID-19 ICU survivors fare?
NCT ID NCT07397156
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 283 adults who needed intensive care for severe COVID-19 lung damage (ARDS) in Poland. Researchers tracked who survived up to 4 years later and asked survivors about their quality of life, breathing, and daily function. No new treatment was tested—the goal was simply to understand long-term outcomes after such a serious illness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal long-term health challenges and recovery patterns after severe COVID-19, helping guide future care and rehabilitation.
- What could go wrong
- This is an observational study with no experimental treatment, so it cannot prove what causes outcomes. Results come from a single center in Poland and may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University in Zielona Góra
Zielona Góra, Lubusz Voivodeship, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?